Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.09
+0.01 (0.06%)
Nov 13, 2026, 4:00 PM EST - Market closed
Relay Therapeutics Employees
Relay Therapeutics had 218 employees as of September 30, 2026. The number of employees increased by 30 or 15.96% compared to the same quarter last year. That makes Relay Therapeutics the 26,212th largest employer in the world and 3,315th in the United States.
Employees
218
Change (1Y)
30
Growth (1Y)
15.96%
Revenue / Employee
$47,477
Profits / Employee
-$1,346,940
Market Cap
4.00B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 218 | 30 | 15.96% |
| Jun 30, 2026 | 202 | 5 | 2.54% |
| Mar 31, 2026 | 193 | -66 | -25.48% |
| Dec 31, 2025 | 192 | -69 | -26.44% |
| Sep 30, 2025 | 188 | -106 | -36.05% |
| Jun 30, 2025 | 197 | -107 | -35.20% |
| Mar 31, 2025 | 259 | -50 | -16.18% |
| Dec 31, 2024 | 261 | -62 | -19.20% |
| Sep 30, 2024 | 294 | -49 | -14.29% |
| Jun 30, 2024 | 304 | -41 | -11.88% |
| Mar 31, 2024 | 309 | -19 | -5.79% |
| Dec 31, 2023 | 323 | -4 | -1.22% |
| Sep 30, 2023 | 343 | 23 | 7.19% |
| Jun 30, 2023 | 345 | 40 | 13.11% |
| Mar 31, 2023 | 328 | 52 | 18.84% |
| Dec 31, 2022 | 327 | 82 | 33.47% |
| Sep 30, 2022 | 320 | 88 | 37.93% |
| Jun 30, 2022 | 305 | 102 | 50.25% |
| Mar 31, 2022 | 276 | 113 | 69.33% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| AbCellera Biologics | 562 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Disc Medicine | 173 |
| Tango Therapeutics | 137 |
RLAY News
- 4 days ago - Relay Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 8 days ago - Relay Therapeutics price target raised to $31 from $20 at Jones - TheFly
- 10 days ago - Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates - GlobeNewsWire
- 10 days ago - Relay Therapeutics Earnings release: Q3 2026 - Filings
- 10 days ago - Relay Therapeutics Quarterly report: Q3 2026 - Filings
- 12 days ago - Relay Therapeutics to Participate in Three Upcoming Investor Conferences in November - GlobeNewsWire
- 17 days ago - Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026 - GlobeNewsWire
- 1 month ago - Relay Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts